Cofirasersen

Modify Date: 2024-01-10 19:23:14

Cofirasersen structure	Common Name	Cofirasersen
	CAS Number	2247669-96-9	Molecular Weight	5437.55
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₇₂H₂₁₈N₅₇O₈₈P₁₅S₁₅	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Cofirasersen

Cofirasersen is designed to reduce the expression of ENaC in the lung. ENaC is a sodium transport channel and believed to be hyperactive in cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane regulator gene.

Name	Cofirasersen

Description	Cofirasersen is designed to reduce the expression of ENaC in the lung. ENaC is a sodium transport channel and believed to be hyperactive in cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane regulator gene.
Related Catalog	Signaling Pathways >> Membrane Transporter/Ion Channel >> Sodium Channel Research Areas >> Others
References	[1]. WHO Drug Information, Vol. 34, No. 3, 2020

Molecular Formula	C₁₇₂H₂₁₈N₅₇O₈₈P₁₅S₁₅
Molecular Weight	5437.55

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Palmitic acid
Price: Check
Purity: 98.0%
Delivery: 10 Day
Contact: Yang
Email: sales@echemcloud.com

Cofirasersen

Use of Cofirasersen

Names

Cofirasersen Biological Activity

Chemical & Physical Properties

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.